Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancerHiromasa Kuroda(Yokohama National University), Tadashi Kimura(Sakai Municipal Hospital)OncotargetNovember 20, 201810.18632/oncotarget.26347Cited by 64SaveCiteExport RISWatch citationsRelated PapersInterleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer|PLoS ONE|2015|80Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary|PLoS ONE|2016|34